Turner Investments’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-6,760
Closed -$1.42M 299
2016
Q4
$1.42M Buy
+6,760
New +$1.4M 0.57% 63
2016
Q2
Sell
-9,305
Closed -$2.5M 261
2016
Q1
$2.5M Sell
9,305
-8,260
-47% -$2.36M 0.68% 49
2015
Q4
$5.49M Sell
17,565
-7,270
-29% -$2.16M 1.14% 23
2015
Q3
$6.75M Sell
24,835
-2,360
-9% -$725K 1.37% 11
2015
Q2
$8.25M Buy
27,195
+7,615
+39% +$2.27M 1.51% 5
2015
Q1
$5.83M Sell
19,580
-6,507
-25% -$1.86M 1.05% 16
2014
Q4
$6.71M Buy
26,087
+6,512
+33% +$1.63M 0.8% 21
2014
Q3
$4.72M Buy
19,575
+4,062
+26% +$909K 0.28% 110
2014
Q2
$3.46M Sell
15,513
-70,031
-82% -$14.5M 0.15% 189
2014
Q1
$17.6M Sell
85,544
-63,578
-43% -$12.6M 0.47% 47
2013
Q4
$25.1M Buy
149,122
+146,809
+6,347% +$23M 0.45% 62
2013
Q3
$333K Sell
2,313
-173,508
-99% -$23.1M 0.01% 517
2013
Q2
$22.2M Buy
+175,821
New +$19.9M 0.3% 120

Other funds holding AGN

Turner Investments's AGN Position: Q1 2017 in Review

Turner Investments sold out of Allergan plc (AGN) in Q1 2017, closing a stake of 6,760 shares — an estimated $1.42M sold.

Turner Investments first reported a position in AGN in Q2 2013 and held it in 13 quarters. The position peaked at $25.1M in Q4 2013. 1,104 funds tracked by Wall St. Rank hold AGN as of Q1 2017.

  • Turner Investments reported no remaining Allergan plc position as of Q1 2017 after selling out during the quarter.
  • Turner Investments sold 6,760 Allergan plc shares in Q1 2017, an estimated $1.42M.
  • Turner Investments first reported a position in Allergan plc in Q2 2013 and held it in 13 quarters.
  • Turner Investments's Allergan plc position peaked at $25.1M in Q4 2013.
  • 1,104 funds tracked by Wall St. Rank held Allergan plc as of Q1 2017.

Based on Turner Investments's 13F filing for Q1 2017, filed 11 May 2017.